Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNT1 | O60563 | 7/20 | 0.65 |
| ▸ | CDK4 | P11802 | 7/20 | 0.65 |
| ▸ | CCND1 | P24385 | 7/20 | 0.65 |
| ▸ | CDK9 | P50750 | 7/20 | 0.65 |
| ▸ | CDK6 | Q00534 | 7/20 | 0.65 |
| ▸ | CDK11A | Q9UQ88 | 7/20 | 0.65 |
| ▸ | CCNA2 | P20248 | 10/20 | 0.54 |
| ▸ | CDK2 | P24941 | 10/20 | 0.54 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.49 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.49 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.49 |
| ▸ | LTK | P29376 | 1/20 | 0.49 |
| ▸ | CLK2 | P49760 | 1/20 | 0.49 |
| ▸ | GSK3A | P49840 | 1/20 | 0.49 |
| ▸ | GSK3B | P49841 | 1/20 | 0.49 |
| ▸ | CDK7 | P50613 | 1/20 | 0.49 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.49 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5726324 | 0.89 | CDK11A (0.82) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL6192863 | 0.85 | CCNT1 (0.61) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL6191533 | 0.82 | CCNA2 (0.63) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL5725752 | 0.82 | CDK2 (0.76) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL6698526 | 0.82 | CCNT1 (0.54) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL6694011 | 0.81 | CCNT1 (0.64) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL5726084 | 0.80 | CCNT1 (0.52) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL5725714 | 0.80 | CCNT1 (0.62) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL5725386 | 0.79 | CDK2 (0.64) | CCNT1CDK4CCND1CDK9CDK6 | |
| SCHEMBL6697935 | 0.78 | CCNA2 (0.69) | CCNT1CDK4CCND1CDK9CDK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040176431-A1 | Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use | PFIZER, INC. | 2004-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176431-A1 | Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use | MKI67, TK1, CDK2 | CCNT1 7/4885CDK4 15/4885CCND1 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.